84 results
DEFA14A
ATXI
Avenue Therapeutics Inc
3 May 24
Additional proxy soliciting materials
6:03pm
Additional Materials
Soliciting Material under §240.14a-12
AVENUE THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated
DEF 14C
ATXI
Avenue Therapeutics Inc
18 Mar 24
Information statement
4:59pm
Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item … stockholders.
HOUSEHOLDING OF STOCKHOLDER MATERIALS
Some bank, brokerage firm or other nominee record holders may be participating in the practice
PRE 14C
ATXI
Avenue Therapeutics Inc
8 Mar 24
Preliminary information
4:31pm
Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item … MATERIALS
Some bank, brokerage firm or other nominee record holders may be participating in the practice of “householding” information statements
DEF 14C
e5r0gjv ds5xr39qki
29 Jan 24
Information statement
8:00am
PRE 14C
vqokmr
17 Jan 24
Preliminary information
5:05pm
8-K
EX-10.1
egg5tj
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
vu7os2c
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
srdh c1j07
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.1
30vx3e5bomn 2nsb3h
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
DEFA14A
sby0pobxbf9 xf
28 Apr 23
Additional proxy soliciting materials
4:15pm